Johns Hopkins Medicine สาธารณะ
[search 0]
เพิ่มเติม

ดาวน์โหลดแอปเลย!

show episodes
 
The Center for Nursing Inquiry oversees the scholarly work of nurses in the Johns Hopkins Health System. Our goal is to build the capacity for nurses to participate in the three forms of inquiry: research, evidence-based practice (EBP), and quality improvement (QI). At the Center for Nursing Inquiry, we offer a variety of educational resources and expert guidance to help nurses engage in meaningful, high-quality scholarly work. We are dedicated to advancing the science of nursing. Stay conne ...
 
Hosted by Bill Curtis and quadruple board certified Dr. Steven Taback, Medicine, We’re Still Practicing sits down with doctors from the world’s most preeminent hospitals for insights into their research, practice, and education. The first in this dedicated series is Johns Hopkins Medicine, with the goal of not only to share the magnificent work being done by these hospitals and doctors, but for them to be able to use it as a high-quality educational tool and platform to share insights and re ...
 
Informative and entertaining stories from the editors of the journal Medicine featuring article highlights, hot topics, and other things on their minds. The journal, published every other month and now in its 90th year, includes scholarly reviews and clinical descriptions of patients from the experience of leading clinicians from around the world in the areas of internal medicine, dermatology, neurology, pediatrics, and psychiatry. The editors, David Hellmann, John Bartlett, Howard Lederman, ...
 
S
Sholem's Bias: Medicine and Other Curiosities

1
Sholem's Bias: Medicine and Other Curiosities

Sholem's Bias: Medicine and Other Curiosities

Unsubscribe
Unsubscribe
รายเดือน
 
In the medical world, I'm an internist and primary care doctor at Johns Hopkins. I see patients, do research on decision-making, uncertainty, and patient-doctor communication; I teach with residents; and I write about the complexities of healthcare. In the non-medical world, I write in English and Yiddish, translating as well between both languages. I publish poetry, short stories, and essays/journalism.
 
Loading …
show series
 
Telehealth, where physician and patient can meet remotely via telephone or video, was utilized by millions when the Covid pandemic was at its height. Now emergency measures to facilitate this are or are about to be expired, and Brian Hasselfeld, director of telemedicine at Johns Hopkins, says perhaps these measures or some like them should […]…
 
Vaccination against the human papilloma virus, or HPV, all but eliminates cervical cancer in those who receive the vaccine early and complete the vaccine series, a study from the UK finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson: The overall story is a really good one. They […]…
 
Telehealth, where physician and patient can meet remotely via telephone or video, was utilized by millions when the Covid pandemic was at its height. Now emergency measures to facilitate this are or are about to be expired, and Brian Hasselfeld, director of telemedicine at Johns Hopkins, says perhaps these measures or some like them should […]…
 
Telehealth, where physician and patient can meet remotely via telephone or video, was utilized by millions when the Covid pandemic was at its height. Now emergency measures to facilitate this are or are about to be expired, and Brian Hasselfeld, director of telemedicine at Johns Hopkins, says perhaps these measures or some like them should […]…
 
Women are a rarity in the biological world, since they will spend up to a third or more of their lives after the point where they cease reproductive ability, at menopause. Wen Shen, a menopause expert at Johns Hopkins, says that fact alone points to a need for greater awareness. Shen: We need to educate […]…
 
Women are a rarity in the biological world, since they will spend up to a third or more of their lives after the point where they cease reproductive ability, at menopause. Wen Shen, a menopause expert at Johns Hopkins, says that fact alone points to a need for greater awareness. Shen: We need to educate […]…
 
Women are a rarity in the biological world, since they will spend up to a third or more of their lives after the point where they cease reproductive ability, at menopause. Wen Shen, a menopause expert at Johns Hopkins, says that fact alone points to a need for greater awareness. Shen: We need to educate […]…
 
The Women’s Health Initiative was a series of studies looking at interventions to improve the health of women after menopause, and in examining hormone therapy, found an increased risk for breast cancer. Wen Shen, a menopause expert at Johns Hopkins, says that study used oral estrogen and that different forms of hormones are used today. […]…
 
The Women’s Health Initiative was a series of studies looking at interventions to improve the health of women after menopause, and in examining hormone therapy, found an increased risk for breast cancer. Wen Shen, a menopause expert at Johns Hopkins, says that study used oral estrogen and that different forms of hormones are used today. […]…
 
The Women’s Health Initiative was a series of studies looking at interventions to improve the health of women after menopause, and in examining hormone therapy, found an increased risk for breast cancer. Wen Shen, a menopause expert at Johns Hopkins, says that study used oral estrogen and that different forms of hormones are used today. […]…
 
Oral estrogen products for women in perimenopause and menopause can be associated with a number of negative side effects. That’s according to Wen Shen, a menopause expert at Johns Hopkins. Shen: Oral estrogen therapy can increase c-reactive protein, which is an inflammatory marker. It increases inflammation. Inflammation affects so much of autoimmu…
 
Oral estrogen products for women in perimenopause and menopause can be associated with a number of negative side effects. That’s according to Wen Shen, a menopause expert at Johns Hopkins. Shen: Oral estrogen therapy can increase c-reactive protein, which is an inflammatory marker. It increases inflammation. Inflammation affects so much of autoimmu…
 
Oral estrogen products for women in perimenopause and menopause can be associated with a number of negative side effects. That’s according to Wen Shen, a menopause expert at Johns Hopkins. Shen: Oral estrogen therapy can increase c-reactive protein, which is an inflammatory marker. It increases inflammation. Inflammation affects so much of autoimmu…
 
Hormone therapy helps women in both perimenopause and menopause cope with symptoms like hot flashes and sleep interruption, but choosing whether to take hormones is complicated. Wen Shen, a menopause expert at Johns Hopkins, offers some insight. Shen: Estrogen therapy depends very strongly on the type of estrogen that you’re prescribed and also the…
 
Hormone therapy helps women in both perimenopause and menopause cope with symptoms like hot flashes and sleep interruption, but choosing whether to take hormones is complicated. Wen Shen, a menopause expert at Johns Hopkins, offers some insight. Shen: Estrogen therapy depends very strongly on the type of estrogen that you’re prescribed and also the…
 
Hormone therapy helps women in both perimenopause and menopause cope with symptoms like hot flashes and sleep interruption, but choosing whether to take hormones is complicated. Wen Shen, a menopause expert at Johns Hopkins, offers some insight. Shen: Estrogen therapy depends very strongly on the type of estrogen that you’re prescribed and also the…
 
Vaccination against the human papilloma virus, or HPV, all but eliminates cervical cancer in those who receive the vaccine early and complete the vaccine series, a study from the UK finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson: The overall story is a really good one. They […]…
 
Vaccination against the human papilloma virus, or HPV, all but eliminates cervical cancer in those who receive the vaccine early and complete the vaccine series, a study from the UK finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson: The overall story is a really good one. They […]…
 
Vaccination against the human papilloma virus, or HPV, all but eliminates cervical cancer in those who receive the vaccine early and complete the vaccine series, a study from the UK finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson: The overall story is a really good one. They […]…
 
Medicare developed a program to rein in the costs of cancer treatment, but the results were disappointing, a new study reveals, with this comprehensive approach reducing costs by about 1%. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says newer therapies may eventually result in lower costs for cancer care. Nelson: Thirty …
 
Medicare developed a program to rein in the costs of cancer treatment, but the results were disappointing, a new study reveals, with this comprehensive approach reducing costs by about 1%. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says newer therapies may eventually result in lower costs for cancer care. Nelson: Thirty …
 
Medicare developed a program to rein in the costs of cancer treatment, but the results were disappointing, a new study reveals, with this comprehensive approach reducing costs by about 1%. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says newer therapies may eventually result in lower costs for cancer care. Nelson: Thirty …
 
Medicare developed a program to rein in the costs of cancer treatment, but the results were disappointing, a new study reveals, with this comprehensive approach reducing costs by about 1%. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says newer therapies may eventually result in lower costs for cancer care. Nelson: Thirty …
 
The Covid-19 spike protein allows it to attach to cells and infect them, and it’s been a primary target for vaccines and antibodies. Now a new monoclonal antibody directed against a region of this protein that really doesn’t change very much has been developed, and Brian Garibaldi, a critical care medicine expert at Johns Hopkins, […]…
 
The Covid-19 spike protein allows it to attach to cells and infect them, and it’s been a primary target for vaccines and antibodies. Now a new monoclonal antibody directed against a region of this protein that really doesn’t change very much has been developed, and Brian Garibaldi, a critical care medicine expert at Johns Hopkins, […]…
 
The Covid-19 spike protein allows it to attach to cells and infect them, and it’s been a primary target for vaccines and antibodies. Now a new monoclonal antibody directed against a region of this protein that really doesn’t change very much has been developed, and Brian Garibaldi, a critical care medicine expert at Johns Hopkins, […]…
 
The Covid-19 spike protein allows it to attach to cells and infect them, and it’s been a primary target for vaccines and antibodies. Now a new monoclonal antibody directed against a region of this protein that really doesn’t change very much has been developed, and Brian Garibaldi, a critical care medicine expert at Johns Hopkins, […]…
 
The Covid-19 spike protein allows it to attach to cells and infect them, and it’s been a primary target for vaccines and antibodies. Now a new monoclonal antibody directed against a region of this protein that really doesn’t change very much has been developed, and Brian Garibaldi, a critical care medicine expert at Johns Hopkins, […]…
 
Another monoclonal antibody against Covid-19 has been developed and appears to work in reducing severe disease and hospitalization. This one is unique, however, according to Brian Garibaldi, a critical care medicine expert at Johns Hopkins. Garibaldi: The interesting thing about the new monoclonal antibody, sotrovimab, this monoclonal antibody was …
 
Another monoclonal antibody against Covid-19 has been developed and appears to work in reducing severe disease and hospitalization. This one is unique, however, according to Brian Garibaldi, a critical care medicine expert at Johns Hopkins. Garibaldi: The interesting thing about the new monoclonal antibody, sotrovimab, this monoclonal antibody was …
 
Another monoclonal antibody against Covid-19 has been developed and appears to work in reducing severe disease and hospitalization. This one is unique, however, according to Brian Garibaldi, a critical care medicine expert at Johns Hopkins. Garibaldi: The interesting thing about the new monoclonal antibody, sotrovimab, this monoclonal antibody was …
 
Another monoclonal antibody against Covid-19 has been developed and appears to work in reducing severe disease and hospitalization. This one is unique, however, according to Brian Garibaldi, a critical care medicine expert at Johns Hopkins. Garibaldi: The interesting thing about the new monoclonal antibody, sotrovimab, this monoclonal antibody was …
 
Another monoclonal antibody against Covid-19 has been developed and appears to work in reducing severe disease and hospitalization. This one is unique, however, according to Brian Garibaldi, a critical care medicine expert at Johns Hopkins. Garibaldi: The interesting thing about the new monoclonal antibody, sotrovimab, this monoclonal antibody was …
 
Loading …

คู่มืออ้างอิงด่วน

Google login Twitter login Classic login